MENLO PARK, Calif., February 2, 2015 - Geron Corporation GERN today announced that John Scarlett, M.D., President and Chief Executive Officer, will present an overview of the company at the 17th Annual BIO CEO & Investor Conference in New York. The presentation is scheduled to occur on Monday, February 9, at 2:00 p.m. Eastern Time.
A live webcast of the presentation will be available through the Investor Relations pages of Geron's website or at http://www.veracast.com/webcasts/bio/ceoinvestor2015/01119294643.cfm. Following the live presentation, the webcast will be archived and available for replay at the same address for a period of 30 days.
About Geron
Geron is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.
CONTACT:
Kevin Eng, Ph.D.
Investor and Media Relations
650-473-7765
investor@geron.com
media@geron.com
###
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Geron Corp. via Globenewswire
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
